Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Study on Brain Imaging for Alzheimer's Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer's Symptoms

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Florquinitau (18F)

Contact Research Centre

Dementia Alzheimer's type+1

Recruiting

InvestigationalNo placebo

Study on the Use of 18F-PI-2620 to Detect Alzheimer's in People with Down Syndrome

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Izaflortaucipir (18F)

Contact Research Centre

Dementia Alzheimer's type+7

Recruiting

Registered drugNo placebo

Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer's Disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Flutemetamol (18F)

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Registered drugNo placebo

Study on Brain Changes in Alzheimer's Disease Using Flutemetamol (18F) and Fludeoxyglucose (18F) in ALFA Project Participants

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Flutemetamol (18F)

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Registered drugNo placebo

Study on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer's Disease

Registered drugNo placebo

The Netherlands

Participants:65+ years · Healthy volunteers
Substances:Flutemetamol (18F)

Contact Research Centre

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Study on How Florquinitau (18F) Affects Brain Circuits in Early Alzheimer's Disease Stages

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Florquinitau (18F)

Contact Research Centre

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Study of Flortaucipir (18F) PET Imaging in Healthy Elderly Twins to Investigate Early Signs of Alzheimer's Disease

InvestigationalNo placebo

The Netherlands

Participants:65+ years · Healthy volunteers
Substances:Flortaucipir (18F)

Contact Research Centre

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

A study using [18F]RO6958948 PET imaging to examine brain tau protein deposits in people at risk of Alzheimer's Disease

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3',4'-D]Pyrrole

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Investigational

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Iti-1284

Contact Research Centre

Dementia Alzheimer's type+2

Recruiting

Investigational

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Iti-1284

Contact Research Centre

Dementia Alzheimer's type+1

Recruiting

Registered drug

Study of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer's disease

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Levetiracetam

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Registered drug

Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Find therapies in clinical trials near you – page 2

87 trials match your criteria

Dementia Alzheimer's type

Study on Brain Imaging for Alzheimer's Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer's Symptoms

Dementia Alzheimer's type+1

Study on the Use of 18F-PI-2620 to Detect Alzheimer's in People with Down Syndrome

Dementia Alzheimer's type+7

Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer's Disease

Dementia Alzheimer's type

Study on Brain Changes in Alzheimer's Disease Using Flutemetamol (18F) and Fludeoxyglucose (18F) in ALFA Project Participants

Dementia Alzheimer's type

Study on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer's Disease

Dementia Alzheimer's type

Study on How Florquinitau (18F) Affects Brain Circuits in Early Alzheimer's Disease Stages

Dementia Alzheimer's type

Study of Flortaucipir (18F) PET Imaging in Healthy Elderly Twins to Investigate Early Signs of Alzheimer's Disease

Dementia Alzheimer's type

A study using [18F]RO6958948 PET imaging to examine brain tau protein deposits in people at risk of Alzheimer's Disease

Dementia Alzheimer's type

Study on ITI-1284 for Treating Agitation in Alzheimer's Patients

Dementia Alzheimer's type+2

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Dementia Alzheimer's type+1

Study of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer's disease

Dementia Alzheimer's type

Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.